Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust tauopathy and memory deficits in a mouse model constitutively overexpressing human P301L MAPT.

Neurobiology of disease·2026
Same author

Rigorous evaluation of pathological α-synucleinopathy transmissibility between animals in an experimental model.

Acta neuropathologica communications·2026
Same author

Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis.

Acta neuropathologica communications·2026
Same author

Efficient induction of motor neuron disease in transgenic G93A SOD1 mice by prion-like seeding.

Prion·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Comparison of the ApoE allelic variants in the formation of intracerebral Aβ deposits.

Neurobiology of disease·2025

Related Experiment Video

Updated: May 11, 2026

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
08:01

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

Normal cognition in transgenic BRI2-Aβ mice.

Jungsu Kim1, Paramita Chakrabarty, Amanda Hanna

  • 1Department of Neuroscience and Center for Translational Research in Neurodegenerative Disease, University of Florida, 1275 Center Drive, Gainesville, FL 32610, USA.

Molecular Neurodegeneration
|May 14, 2013
PubMed
Summary

High levels of amyloid-beta peptides alone do not cause cognitive decline in mice. This suggests amyloid precursor protein (APP) overexpression or its derivatives may be key drivers of memory deficits in Alzheimer's disease models.

More Related Videos

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Related Experiment Videos

Last Updated: May 11, 2026

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
08:01

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) research implicates amyloid-beta (Aβ) in cognitive impairment.
  • Transgenic mouse models overexpressing amyloid precursor protein (APP) exhibit AD-like pathology and cognitive deficits.

Purpose of the Study:

  • To investigate the cognitive impact of Aβ peptides produced independently of APP overexpression.
  • To examine the BRI2-Aβ transgenic mouse model for Aβ-mediated cognitive impairment.

Main Methods:

  • Utilized BRI2-Aβ transgenic mice producing extracellular Aβ1-40, Aβ1-42, or both.
  • Assessed cognitive performance using established behavioral tests.
  • Compared cognitive function pre and post amyloid plaque formation.

Main Results:

  • BRI2-Aβ1-42 mice showed intact cognitive performance despite amyloid pathology.
  • Mice producing Aβ1-40 or both Aβ peptides also exhibited normal cognition.
  • No memory deficits were observed in BRI2-Aβ models.

Conclusions:

  • Elevated Aβ1-40 or Aβ1-42 alone does not replicate memory deficits seen in APP transgenic models.
  • APP overexpression or its processing derivatives may be critical for cognitive decline.
  • The BRI2-Aβ model may not fully recapitulate Aβ's cognitive impact mechanisms.